O-GlcNAc modification of PPARγ reduces its transcriptional activity

被引:63
|
作者
Ji, Suena [2 ]
Park, Sang Yoon [2 ]
Roth, Juergen [3 ]
Kim, Hoe Suk [1 ]
Cho, Jin Won [2 ,3 ]
机构
[1] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul 110744, South Korea
[2] Yonsei Univ, Dept Biol, Seoul 120749, South Korea
[3] Yonsei Univ, Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea
基金
新加坡国家研究基金会;
关键词
O-GlcNAc; PPAR gamma; Adipogenesis; 3T3-L1; ACTIVATED RECEPTOR-GAMMA; N-ACETYLGLUCOSAMINE; C/EBP-ALPHA; INSULIN-RESISTANCE; MASS-SPECTROMETRY; GENE PROMOTER; ADIPOGENESIS; BETA; EXPRESSION; GLCNACYLATION;
D O I
10.1016/j.bbrc.2011.12.086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The peroxisome proliferator-activated receptor gamma (PPAR gamma), a member of the nuclear receptor superfamily, is a key regulator of adipogenesis and is important for the homeostasis of the adipose tissue. The beta-O-linked N-acetylglucosamine (O-GlcNAc) modification, a posttranslational modification on various nuclear and cytoplasmic proteins, is involved in the regulation of protein function. Here, we report that PPAR gamma is modified by O-GIcNAc in 3T3-L1 adipocytes. Mass spectrometric analysis and mutant studies revealed that the threonine 54 of the N-terminal AF-1 domain of PPAR gamma is the major O-GlcNAc site. Transcriptional activity of wild type PPAR gamma was decreased 30% by treatment with the specific O-GlcNAcase (OGA) inhibitor, but the T54A mutant of PPAR gamma did not respond to inhibitor treatment. In 3T3-L1 cells, an increase in O-GlcNAc modification by OGA inhibitor reduced PPAR gamma transcriptional activity and terminal adipocyte differentiation. Our results suggest that the O-GlcNAc state of PPAR gamma influences its transcriptional activity and is involved in adipocyte differentiation. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1158 / 1163
页数:6
相关论文
共 50 条
  • [1] O-GlcNAc modification of FoxO1 increases its transcriptional activity:: A role in the glucotoxicity phenomenon?
    Kuo, MeiShiue
    Zilberfarb, Vladimir
    Gangneux, Nicolas
    Christeff, Nevena
    Issad, Tarik
    BIOCHIMIE, 2008, 90 (05) : 679 - 685
  • [2] O-GlcNAc modification of CaMKIV
    Dias, Wagner Barbosa
    Cheung, Win
    Wang, Zihao
    Hart, Gerald
    FASEB JOURNAL, 2008, 22
  • [3] The O-GlcNAc Modification on Kinases
    Schwein, Paul A.
    Woo, Christina M.
    ACS CHEMICAL BIOLOGY, 2020, 15 (03) : 602 - 617
  • [4] O-GlcNAc Modification and Its Role in Diabetic Retinopathy
    Liu, Chengzhi
    Dong, Wenkang
    Li, Jun
    Kong, Ying
    Ren, Xiang
    METABOLITES, 2022, 12 (08)
  • [5] O-GlcNAc in transcriptional repression of genes
    Kudlow, JE
    FASEB JOURNAL, 2005, 19 (05): : A1374 - A1374
  • [6] Transcriptional regulation of O-GlcNAc homeostasis
    Qian, Kevin
    Ruan, Hai-Bin
    Yang, Xiaoyong
    FASEB JOURNAL, 2014, 28 (01):
  • [7] Regulation of CaMKIV by O-GlcNAc modification
    Dias, Wagner B.
    Cheung, Win D.
    Wang, Zihao
    Hart, Gerald W.
    GLYCOBIOLOGY, 2008, 18 (11) : 991 - 991
  • [8] O-GlcNAc modification and metabolism in cancer
    Pratt, Matthew R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [9] Investigation of the O-GlcNAc modification of APP
    Werner, S
    Koch, J
    Schmitz, B
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 213 - 213
  • [10] Regulation of the Transcriptional Machinery by O-Glcnac Cycling
    Love, Dona
    Ghosh, Salil
    Wang, Peng
    Keembiyehetty, Chithra
    Fukushige, Tetsunari
    Krause, Michael
    Hanover, John
    GLYCOBIOLOGY, 2009, 19 (11) : 1371 - 1371